Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2005 Nov;19(6):521-7.
doi: 10.1007/s00482-004-0342-2.

[Endogenous cannabinoid system. Effect on neuronal plasticity and pain memory]

[Article in German]
Affiliations

[Endogenous cannabinoid system. Effect on neuronal plasticity and pain memory]

[Article in German]
S C Azad et al. Schmerz. 2005 Nov.

Abstract

Aim: The aim of this study was to evaluate the role of the endogenous cannabinoid system in controlling neuroplasticity.

Methods: The pain threshold for electrical stimuli was determined in transgenic mice lacking the cannabinoid receptor type 1 (CB1(-/-)) and in the corresponding respective wild-type animals. Electrophysiological experiments were performed in prepared brain slices to test the effect of endogenous and exogenous cannabinoids on synaptic transmission and long-term potentiation (LTP) in the amygdala.

Results: The pain threshold was nearly identical in both groups for the first pain induction; however, with repeated pain induction it decreased to a significantly greater extent in the CB1(-/-) mice than in the wild-type animals. Synoptic transmission and the inducibility of LTP were not influenced by the acute pharmacological blockade of CB1 receptors, but inhibited by the CB1 agonist WIN55,212-2.

Conclusion: The endogenous cannabinoid system is involved in the control of neuroplasticity as part of pain processing . Cannabinoids prevent the formation of LTP in the amygdala via activation of CB1 receptors. Synoptic transmission and the inducibility of LTP were not influenced by the acute pharmacological blockade of CB1 receptors, but inhibited by the CB1 agonist Win55,212-2.

PubMed Disclaimer

References

    1. J Neurophysiol. 2000 Jun;83(6):3287-93 - PubMed
    1. Nat Neurosci. 2002 May;5(5):446-51 - PubMed
    1. Trends Neurosci. 1994 May;17(5):208-14 - PubMed
    1. Prog Neurobiol. 2001 Apr;63(5):569-611 - PubMed
    1. Nature. 1997 Dec 11;390(6660):604-7 - PubMed

Publication types

LinkOut - more resources